F8 mutation screen for haemophilia A

Description
Analysis of the F8gene by PCR amplification and sequencing of the coding region and splice junctions is the gold standard approach.Dosage analysis, via MLPA, is available as a second line test where gross deletions/ insertions are suspected. Analysis of common F8 inversion mutations is performed as a first line test on patients with a severe phenotype.
Clinical details
Haemophilia A is an X-linked bleeding disorder of variable severity. Severe deficiency of factor VIII clotting activity is associated with spontaneous joint or deep tissue bleeding. Moderate or mild deficiency is associated with prolonged bleeding after tooth extractions, surgery, or injuries and recurrent or delayed wound healing. Haemophilia A has a world-wide incidence of approximately 1 in 5000 live male births.
Related condition
Reference range

n/a

Units
n/a
Synonyms
F8 Haemophilia A Factor VIII deficiency X-linked bleeding
Testing site
Synnovis : Genomics : St Thomas' Hospital
Laboratory
Molecular Haemostasis
Sample type and volume required
1 x Edta
Call in advance
no
Storage and transport
transport at ambient temperature
Turnaround time
8 weeks
Contacts

Molecular Haemostasis Laboratory at St Thomas’ Hospital
Phone: 020 7188 2798
Haemostasis and Thrombosis
North Wing – 4th floor
St Thomas’ Hospital
Westminster Bridge Road
London SE1 7EH
Laboratory opening times
Monday – Friday 09.00 – 17.00

Last updated:

Back to search